Premium Free Dispensing Incentive (PFDI)
From 1 July 2010, a fee of $1.53 will be paid to approved suppliers for each substitutable brand dispensed where a premium does not apply. Approved hospital authorities located at a public hospital that has implemented pharmaceutical reforms —under Part B15, Schedule B of the National Health Care Agreement—are not eligible to receive this fee.
The amount of $1.53 will be indexed annually.
The PFDI is not payable for General Pharmaceutical Benefits dispensed where the Australian Government price is less than or equal to the general patient contribution.
Last updated: 25 July, 2011